How have ALIOF shares performed this year?

ALIOF's stock was trading at $278.50 at the beginning of 2024. Since then, ALIOF stock has increased by 0.0% and is now trading at $278.50. View the best growth stocks for 2024 here .

How were ALIOF's earnings last quarter?

ALIOF (OTCMKTS:ALIOF) announced its quarterly earnings data on Monday, February, 16th. The company reported $0.87 earnings per share for the quarter, missing the consensus estimate of $1.09 by $0.22. The firm had revenue of $501.50 million for the quarter, compared to analyst estimates of $546.30 million.

How do I buy shares of ALIOF?

Shares of ALIOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ALIOF

ALIOF (ALIOF) Stock Price, News & Analysis

$278.50

0.00 (0.00%)

(As of 09/27/2022)

Compare

Today's Range: $278.50
▼
$278.50
50-Day Range: $278.50
▼
$278.50
52-Week Range: $138.01
▼
$286.30

Volume: N/A
Average Volume: 924 shs
Market Capitalization: $29.89 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get ALIOF alerts:

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

About ALIOF Stock (OTCMKTS:ALIOF)

Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.

ALIOF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ALIOF Stock News Headlines

August 24, 2023 | thestreet.com

5 Things You Must Know Before the Market Opens Friday

May 5, 2023 | msn.com

India goes Digital: 5 major indicators of MASSIVE transformation

See More Headlines

Receive ALIOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALIOF and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/16/2015
Today: 7/27/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medicinals & Botanicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:ALIOF
CUSIP: N/A
CIK: N/A
Web: www.actelion.com
Phone: (161) 565-6565
Fax: 41-61-565-6500
Employees: N/A
Year Founded: 1997

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 107,330,000
Free Float: N/A
Market Cap: $29.89 billion
Optionable: Not Optionable
Beta: N/A

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Nicholas Franco
Chief Business Development Officer & EVP

Key Competitors

View All Competitors

Should I Buy ALIOF Stock? ALIOF Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in ALIOF:

Actelion Ltd. is a pharmaceutical company that develops, produces, and markets pharmaceutical drugs, which can provide stable revenue streams.
Recent developments in the pharmaceutical industry have shown increased demand for innovative drugs, potentially benefiting ALIOF's product portfolio.
ALIOF's research, development, and manufacturing capabilities can lead to the creation of breakthrough pharmaceutical products, attracting investor interest.
With a strong focus on medicinal and botanical products, ALIOF is positioned to capitalize on the growing trend towards natural healthcare solutions.
Considering the current stock price of ALIOF, investors may find an entry point that offers potential for future growth.

Cons

Investors should be bearish about investing in ALIOF for these reasons:

Market volatility in the pharmaceutical sector can impact ALIOF's stock performance, leading to fluctuations in investment returns.
Regulatory challenges and approval processes in the pharmaceutical industry may delay product launches, affecting revenue generation.
Competition from other pharmaceutical companies could pose a threat to ALIOF's market share and profitability.
Economic uncertainties and global health crises can influence consumer spending on pharmaceutical products, impacting ALIOF's sales.
Investors should carefully consider the risks associated with investing in individual pharmaceutical companies like ALIOF, including clinical trial outcomes and patent expirations.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, July 23, 2024. Please send any questions or comments about these ALIOF pros and cons to contact@marketbeat.com.

ALIOF Stock Analysis - Frequently Asked Questions

How have ALIOF shares performed this year?: ALIOF's stock was trading at $278.50 at the beginning of 2024. Since then, ALIOF stock has increased by 0.0% and is now trading at $278.50.
View the best growth stocks for 2024 here.
How were ALIOF's earnings last quarter?: ALIOF (OTCMKTS:ALIOF) announced its quarterly earnings data on Monday, February, 16th. The company reported $0.87 earnings per share for the quarter, missing the consensus estimate of $1.09 by $0.22. The firm had revenue of $501.50 million for the quarter, compared to analyst estimates of $546.30 million.
How do I buy shares of ALIOF?: Shares of ALIOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.